Lateralized caudate metabolic abnormalities in adolescent major depressive disorder: A proton MR spectroscopy study

被引:66
作者
Gabbay, Vilma
Hess, David A.
Liu, Songtao
Babb, James S.
Klein, Rachel G.
Gonen, Oded
机构
[1] NYU, Sch Med, Dept Psychiat, NYU Child Study Ctr, New York, NY 10016 USA
[2] NYU, Sch Med, Dept Radiol, New York, NY 10016 USA
关键词
D O I
10.1176/appi.ajp.2007.06122032
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
Objective: Proton magnetic resonance spectroscopy (H-1-MRS) has been increasingly used to examine striatal neurochemistry in adult major depressive disorder. This study extends the use of this modality to pediatric major depression to test the hypothesis that adolescents with major depression have elevated concentrations of striatal choline and creatine and lower concentrations of N-acetylaspartate. Method: Fourteen adolescents (ages 1219 years, eight female) who had major depressive disorder for at least 8 weeks and a severity score of 40 or higher on the Children's Depression Rating Scale-Revised and 10 healthy comparison adolescents (six female) group-matched for gender, age, and handedness were enrolled. All underwent three-dimensional 3-T H-1-MRS at high spatial resolution (0.75-cm(3) voxels). Relative levels of choline, creatine, and N-acetylaspartate in the left and right caudate, putamen, and thalamus were scaled into concentrations using phantom replacement, and levels were compared for the two cohorts. Results: Relative to comparison subjects, adolescents with major depressive disorder had significantly elevated concentrations of choline (2.11 mM versus 1.56 mM) and creatine (6.65 mM versus 5.26 mM) in the left caudate. No other neurochemical differences were observed between the groups. Conclusions: These findings most likely reflect accelerated membrane turnover and impaired metabolism in the left caudate. The results are consistent with prior imaging reports of focal and lateralized abnormalities in the caudate in adult major depression.
引用
收藏
页码:1881 / 1889
页数:9
相关论文
共 66 条
[1]   GLUCOCORTICOIDS INHIBIT SOLUBLE PHOSPHOLIPASE-C ACTIVITY AND CYTOSOLIC GUANINE-NUCLEOTIDE REGULATORY PROTEIN-ALPHA-I IMMUNOREACTIVITY IN SPLEEN [J].
AKOMPONG, T ;
SPENCER, RL ;
MCEWEN, BS .
ENDOCRINOLOGY, 1993, 133 (05) :1963-1970
[2]   Functions of N-acetyl-L-aspartate and N-acetyl-L-aspartylglutamate in the vertebrate brain:: Role in glial cell-specific signaling [J].
Baslow, MH .
JOURNAL OF NEUROCHEMISTRY, 2000, 75 (02) :453-459
[3]   Reduced volume of limbic system-affiliated basal ganglia in mood disorders: Preliminary data from a postmortem study [J].
Baumann, B ;
Danos, P ;
Krell, D ;
Diekmann, S ;
Leschinger, A ;
Stauch, R ;
Wurthmann, C ;
Bernstein, HG ;
Bogerts, B .
JOURNAL OF NEUROPSYCHIATRY AND CLINICAL NEUROSCIENCES, 1999, 11 (01) :71-78
[4]  
BAXTER LR, 1985, ARCH GEN PSYCHIAT, V42, P441
[5]   Childhood and adolescent depression: A review of the past 10 years .1. [J].
Birmaher, B ;
Ryan, ND ;
Williamson, DE ;
Brent, DA ;
Kaufman, J ;
Dahl, RE ;
Perel, J ;
Nelson, B .
JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY, 1996, 35 (11) :1427-1439
[6]  
Brent D A, 1993, Pediatr Rev, V14, P380, DOI 10.1542/pir.14-10-380
[7]   FRONTAL-CORTEX AND BASAL GANGLIA METABOLIC RATES ASSESSED BY POSITRON EMISSION TOMOGRAPHY WITH [F-18] 2-DEOXYGLUCOSE IN AFFECTIVE-ILLNESS [J].
BUCHSBAUM, MS ;
WU, J ;
DELISI, LE ;
HOLCOMB, H ;
KESSLER, R ;
JOHNSON, J ;
KING, AC ;
HAZLETT, E ;
LANGSTON, K ;
POST, RM .
JOURNAL OF AFFECTIVE DISORDERS, 1986, 10 (02) :137-152
[8]   Proton spectroscopy study of the left dorsolateral prefrontal cortex in pediatric depressed patients [J].
Caetano, SC ;
Fonseca, M ;
Olvera, RL ;
Nicoletti, M ;
Hatch, JP ;
Stanley, JA ;
Hunter, K ;
Lafer, B ;
Pliszka, SR ;
Soares, JC .
NEUROSCIENCE LETTERS, 2005, 384 (03) :321-326
[9]  
CHAKOS MH, 1994, AM J PSYCHIAT, V151, P1430
[10]   BRAIN CHOLINE IN DEPRESSION - IN-VIVO DETECTION OF POTENTIAL PHARMACODYNAMIC EFFECTS OF ANTIDEPRESSANT THERAPY USING HYDROGEN LOCALIZED SPECTROSCOPY [J].
CHARLES, HC ;
LAZEYRAS, F ;
KRISHNAN, KRR ;
BOYKO, OB ;
PAYNE, M ;
MOORE, D .
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 1994, 18 (07) :1121-1127